Wagstaff, J., Porta, C., Levy, A., Hawkins, R., Castellano, D., Bellmunt, J., . . . Duh, M. S. (2014). Impact of adverse events, treatment modifications, and dose intensity on survival among patients with advanced renal cell carcinoma treated with first‐line sunitinib: A medical chart review across ten centers in five European countries. Cancer Medicine, 3(6), pp. 1517-1526. doi:10.1002/cam4.302

Wagstaff, John, et al. "Impact of Adverse Events, Treatment Modifications, and Dose Intensity On Survival Among Patients With Advanced Renal Cell Carcinoma Treated With First‐line Sunitinib: A Medical Chart Review Across Ten Centers in Five European Countries." Cancer Medicine 3, no. 6 (2014): 1517-1526.

Wagstaff, John, et al. "Impact of Adverse Events, Treatment Modifications, and Dose Intensity On Survival Among Patients With Advanced Renal Cell Carcinoma Treated With First‐line Sunitinib: A Medical Chart Review Across Ten Centers in Five European Countries." Cancer Medicine 3.6 (2014): 1517-1526.